Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nisha Thampi

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Heliyon|March 5, 2024
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infectionZaeema Naveed, Cherry Chu, Mina Tadrous, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Plasmid genomic epidemiology of <i>bla</i><sub>KPC</sub> carbapenemase-producing <i>Enterobacterales</i> in Canada, 2010-2021Nicole Lerminiaux, Robyn Mitchell, Jessica Bartoszko, et al.
Infection Control and Hospital Epidemiology|March 7, 2022
Antimicrobial use in Canadian acute-care hospitals: Findings from three national point-prevalence surveys between 2002 and 2017Jennifer J Liang, Wallis Rudnick, Robyn Mitchell, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 8, 2024
Nirmatrelvir-ritonavir use among adults hospitalized with COVID-19 during the Omicron phase of the COVID-19 pandemic, Canadian Nosocomial Infection Surveillance ProgramRobyn Mitchell, Diane Lee, Linda Pelude, et al.
JAMA Network Open|April 20, 2023
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022Robyn Mitchell, Joelle Cayen, Nisha Thampi, et al.
Antimicrobial Resistance and Infection Control|July 12, 2025
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023Robyn Mitchell, Laura Mataseje, Joëlle Cayen, et al.
Infection Control and Hospital Epidemiology|December 19, 2024
The adoption and compliance to central line-associated bloodstream infection insertion and maintenance bundle programs in intensive care unit settings across CanadaZhi Lin Zhou, Anada Silva, Kristine Cannon, et al.
Infection Control and Hospital Epidemiology|August 18, 2022
Trends in <i>Clostridioides difficile</i> infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemicKelly B Choi, Tim Du, Anada Silva, et al.
Emerging Infectious Diseases|April 26, 2022
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019Tim Du, Kelly B Choi, Anada Silva, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 27, 2018
The evolving epidemiology of <i>Clostridium difficile</i> infection in Canadian hospitals during a postepidemic period (2009-2015)Kevin C Katz, George R Golding, Kelly Baekyung Choi, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Heliyon|March 5, 2024
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infectionZaeema Naveed, Cherry Chu, Mina Tadrous, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2023
Plasmid genomic epidemiology of <i>bla</i><sub>KPC</sub> carbapenemase-producing <i>Enterobacterales</i> in Canada, 2010-2021Nicole Lerminiaux, Robyn Mitchell, Jessica Bartoszko, et al.
Infection Control and Hospital Epidemiology|March 7, 2022
Antimicrobial use in Canadian acute-care hospitals: Findings from three national point-prevalence surveys between 2002 and 2017Jennifer J Liang, Wallis Rudnick, Robyn Mitchell, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|March 8, 2024
Nirmatrelvir-ritonavir use among adults hospitalized with COVID-19 during the Omicron phase of the COVID-19 pandemic, Canadian Nosocomial Infection Surveillance ProgramRobyn Mitchell, Diane Lee, Linda Pelude, et al.
JAMA Network Open|April 20, 2023
Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022Robyn Mitchell, Joelle Cayen, Nisha Thampi, et al.
Antimicrobial Resistance and Infection Control|July 12, 2025
The evolving epidemiology of Carbapenemase-producing Enterobacterales in Canadian acute care facilities, 2010-2023Robyn Mitchell, Laura Mataseje, Joëlle Cayen, et al.
Infection Control and Hospital Epidemiology|December 19, 2024
The adoption and compliance to central line-associated bloodstream infection insertion and maintenance bundle programs in intensive care unit settings across CanadaZhi Lin Zhou, Anada Silva, Kristine Cannon, et al.
Infection Control and Hospital Epidemiology|August 18, 2022
Trends in <i>Clostridioides difficile</i> infection rates in Canadian hospitals during the coronavirus disease 2019 (COVID-19) pandemicKelly B Choi, Tim Du, Anada Silva, et al.
Emerging Infectious Diseases|April 26, 2022
Characterization of Healthcare-Associated and Community-Associated Clostridioides difficile Infections among Adults, Canada, 2015-2019Tim Du, Kelly B Choi, Anada Silva, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 27, 2018
The evolving epidemiology of <i>Clostridium difficile</i> infection in Canadian hospitals during a postepidemic period (2009-2015)Kevin C Katz, George R Golding, Kelly Baekyung Choi, et al.
Pageof 7